Antares Pharma, Inc. (ATRS) Social Stream
ANTARES PHARMA INC (ATRS) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ATRS.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
ATRS's average price target has moved down $0.47 over the prior 14 months.
ATRS reports an average of 66.78% for its upside potential over the past 47 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
ATRS Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 121 days, ATRS's average broker recommendation rating worsened by 1.33.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, ANTARES PHARMA INC's average analyst price target is greater than 26.66% of them.
- ANTARES PHARMA INC's upside potential (average analyst target price relative to current price) is higher than 52.71% of Medical Equipment stocks.
- To contextualize these metrics, consider that out of stocks in the small market cap category, ANTARES PHARMA INC's number of analysts covering the stock is higher than 462.6% of them.
- In terms of how ANTARES PHARMA INC fares relative to Medical Equipment stocks, note that its variance in analysts' estimates is lower than -231.39% of that group.
Is ATRS a Buy, Hold or Sell? See the POWR Ratings now!